# Nu-Med Plus, Inc. (NUMD)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NUMD/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -15.9K | $ -6.4K | $ 122.5K | $ -287.2K |
| 2025 | $ 0 | $ -57.5K | $ -49.1K | $ 112.5K | $ -271.3K |
| 2024 | $ 631 | $ -71.8K | $ -4.7K | $ 100.0K | $ -215.1K |
| 2023 | $ 0 | $ -135.7K | $ -71.8K | $ 100.0K | $ -146.8K |
| 2022 | $ 0 | $ -145.4K | $ -43.0K | $ 100.0K | $ -63.0K |
| 2021 | $ 0 | $ -986.1K | $ -245.9K | $ 8.2K | $ -132.4K |
| 2020 | $ 0 | $ -2.56M | $ -528.4K | $ 17.4K | $ 467.7K |
| 2019 | $ 0 | $ -1.34M | $ -732.3K | $ 238.5K | $ -370.4K |
| 2018 | $ 0 | $ -1.57M | $ -617.5K | $ 241.1K | $ 48.5K |
| 2017 | $ 0 | $ 4.82M | $ -580.0K | $ 250.1K | $ 68.2K |
| 2016 | $ 0 | $ 28.32M | $ -248.0K | $ 315.9K | $ -4.44M |
| 2015 | $ 0 | $ -1.56M | $ -462.5K | $ 234.7K | $ -403.2K |
| 2014 | $ 0 | $ -1.69M | $ -225.2K | $ 230.1K | $ -53.8K |
| 2013 | $ 0 | $ -472.6K | $ -240.9K | $ 199.4K | $ -124.3K |
| 2012 | $ 0 | $ -379.3K | $ -150.4K | $ 138.5K | $ -46.1K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.43 |
| Liabilities / Eq | -1.03 |
| Current Ratio | 0.02 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 0.11 |

## Other views

- [Metrics](https://sponda.capital/en/NUMD.md)
- [Charts](https://sponda.capital/en/NUMD/charts.md)
- [Compare](https://sponda.capital/en/NUMD/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.